Evaluating the Clinical Efficacy and Safety of Luspatercept Combined With Thalidomide in the Treatment of β-TDT Patients

Recruiting

Phase 2 — Testing in a larger group (up to a few hundred people) to further evaluate safety and begin to assess effectiveness.

Trial locations(8 sites)

China

Southern Medical University Shenzhen Hospital, Shenzhen, Guangdong

Affiliated Hospital of Youjiang Medical College for Nationalities, Baise City, Guangxi

Baise People's Hospital, Baise City, Guangxi

Liuzhou People's Hospital, Liuchow, Guangxi

Liuzhou Workers' Hospital, Liuchow, Guangxi

Yulin First People's Hospital, Yulin, Guangxi

Yunnan Provincial First People's Hospital, Kunming, Yunnan

The First Affiliated Hospital of Guangxi Medical University, Naning